Nox1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
NOX1 (NADPH Oxidase 1) is a gene located on chromosome Xq22 that encodes NADPH oxidase 1, a member of the NOX family of reactive oxygen species (ROS)-generating enzymes[1]. While primarily studied in colon epithelium and other non-neuronal cells, NOX1 is expressed in certain neuronal populations and glial cells within the brain. Excessive NOX1 activity contributes to oxidative stress, neuroinflammation, and neuronal death in Alzheimer's disease, Parkinson's disease, and stroke[2].
NOX1 differs from other NOX isoforms in its requirement for specific regulatory subunits and its activation by various growth factors and cytokines. Understanding NOX1's role in neurodegeneration has revealed it as a potential therapeutic target.
| NADPH Oxidase 1 | |
|---|---|
| Gene Symbol | NOX1 |
| Full Name | NADPH Oxidase 1 |
| Chromosome | Xq22 |
| NCBI Gene ID | [27035](https://www.ncbi.nlm.nih.gov/gene/27035) |
| OMIM | 300225 |
| Ensembl ID | ENSG00000156508 |
| UniProt ID | [Q9Y5S5](https://www.uniprot.org/uniprot/Q9Y5S5) |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Stroke, Inflammatory Disorders |
NOX1 encodes a protein of approximately 564 amino acids with a molecular weight of ~65 kDa. The protein structure includes:
NOX1 requires assembly with specific regulatory subunits:
| Subunit | Function | Role |
|---|---|---|
| NOXO1 | Organizer | Scaffold for complex assembly |
| NOXA1 | Activator | Enhances enzymatic activity |
| p22phox | Partner | Stabilizes NOX1 membrane integration |
NOX1 generates superoxide anion (O₂⁻) through electron transfer:
NADPH → FAD → heme → O₂ → O₂⁻
NOX1 expression in the central nervous system:
NOX1 contributes to AD pathogenesis through multiple mechanisms[3]:
In PD, NOX1 promotes dopaminergic neuron death[4]:
NOX1 is upregulated following ischemic injury:
| Stimulus | Receptor | Signaling Cascade |
|---|---|---|
| Angiotensin II | AT1R | PLC → PKC → NOX1 |
| PDGF | PDGFR | PI3K → Rac → NOX1 |
| TNF-α | TNFR1 | NF-κB → NOX1 expression |
| LPA | LPAR | GPCR → PLC → NOX1 |
| EGF | EGFR | MAPK → NOX1 |
| Compound | Specificity | Development Stage |
|---|---|---|
| ML171 | NOX1 | Preclinical |
| GKT137831 | NOX1/NOX4 | Phase 2 trials |
| Pyrazolopyridine derivatives | NOX1 | Preclinical |
NOX1 activity can be assessed through:
The study of Nox1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Bedard & Krause, The NOX family of ROS-generating NADPH oxidases (2007). Physiol Rev. 2007. ↩︎
Sorce & Krause, NOX enzymes in the central nervous system (2009). J Neurochem. 2009. ↩︎
Park et al. NOX isoforms in Alzheimer's disease (2015). J Alzheimers Dis. 2015. ↩︎
Surace & Block, NOX in Parkinson's disease (2012). Neuroscience. 2012. ↩︎